238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
View analysts' price targets and recommendations, and compare them with competitors.
$187.00
Analysts expect the stock price to decrease by 22.34%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
363.02B
Revenue has increased from the previous period.
18.10%
Revenue growth rate has increased from the previous period.
123.49B
EBITDA has increased from the previous period.
34.02%
EBITDA margin has increased from the previous period.
102.97B
EBIT has increased from the previous period.
28.36%
EBIT margin has increased from the previous period.
20.52B
Depreciation has increased from the previous period.
202.81B
Total cash has increased from the previous period.
55.87%
Cash percentage has increased from the previous period.
57.55B
Receivables have increased from the previous period.
15.85%
Receivables percentage has increased from the previous period.
1.75B
Inventories have increased from the previous period.
0.48%
Inventory percentage has increased from the previous period.
9.51B
Accounts payable has increased from the previous period.
2.62%
Payables percentage has increased from the previous period.
-42.07B
Capital expenditure has increased from the previous period.
-11.59%
CapEx percentage has increased from the previous period.
9.08%
WACC is unchanged from the previous period.
9.14%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.03
Beta is unchanged from the previous period.
12.72B
Diluted shares outstanding is unchanged from the previous period.
28.50B
Total debt is unchanged from the previous period.
2.49T
Total equity is unchanged from the previous period.
2.51T
Total capital is unchanged from the previous period.
1.13%
Debt weighting is unchanged from the previous period.
98.87%
Equity weighting is unchanged from the previous period.
87.40B
EBIAT has increased from the previous period.
56.52B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
2.32T
Terminal value is unchanged from the previous period.
1.82T
Enterprise value has increased from the previous period.
4.46B
Net debt is unchanged from the previous period.
1.81T
Equity value has increased from the previous period.
142.33
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
436.13B
The estimated revenue has increased from the previous period.
148.36B
The estimated EBITDA has increased from the previous period.
10.29
The estimated EPS has increased from the previous period.
122.61B
The estimated net income has increased from the previous period.
123.71B
The estimated EBIT has increased from the previous period.
66.91B
The estimated SG&A expenses have increased from the previous period.
